Daily non-political popular news in brief.
Chemotherapy may enhance the effectiveness of brain tumor vaccines
06-03-2007 · EurekAlert!Chemotherapy temporarily hinders the body's immune response, creating a concern that it may interfere with the promising new cancer vaccines being used against brain tumors. But a new study led by researchers at the Preston Robert Tisch Brain Tumor Center at Duke University and The University of Texas M. D. Anderson Cancer Center has found that the opposite is true: chemotherapy may actually enhance the effectiveness of the vaccines.
Read more »
Keywords: chemotherapy, enhance, effectiveness, brain, tumor, vaccines, vaccine
« Previous | Next »
Similar news on "Chemotherapy may enhance the effectiveness of brain tumor vaccines":
- Blood-vessel blocker aids cancer-killing virus
11-27-2007 · EurekAlert!
Cancer-killing viruses are a promising therapy for incurable brain tumors, but their effectiveness has been limited in part because immune cells rapidly eliminate them. That immune response might be slowed, and the virus given more time to kill cancer cells, by blocking the growth of blood vessels in the tumor, new Ohio State research suggests. The study indicates that pretreatment with a drug that blocks blood-vessel growth might improve the effectiveness of cancer-killing viruses.
Similar news · Read more »
- Blood test may help signal tumor's remission, return in throat cancer patients
06-01-2007 · EurekAlert!
A blood test that detects proteins commonly released by a growing tumor could one day become a useful tool for monitoring the effectiveness of chemotherapy and radiation treatment in people with advanced throat cancer, according to a study published in the June 1, 2007, issue of Clinical Cancer Research.
Similar news · Read more »
- Phase II study of therapeutic vaccine shows efficacy in patients with metastatic colorectal cancer
08-01-2007 · EurekAlert!
A therapeutic cancer vaccine has shown effectiveness when given alongside chemotherapy to patients with metastatic colorectal cancer in a phase II trial, according to research published in the Aug. 1 issue of the journal Clinical Cancer Research.
Similar news · Read more »
- Drug helps brain tumor patients live longer
01-28-2008 · EurekAlert!
People who receive high doses of the chemotherapy drug methotrexate to treat a certain type of brain tumor appear to live longer than people receiving other treatments, according to research published in the Jan. 29, 2008, issue of Neurology, the medical journal of the American Academy of Neurology.
Similar news · Read more »
- Clinical trial evaluating brain cancer vaccine is underway at NYU
10-18-2007 · EurekAlert!
A clinical trial evaluating a brain cancer vaccine in patients with newly diagnosed brain cancer has begun at NYU Medical Center. The study will evaluate the addition of the vaccine following standard therapy with surgery and chemotherapy in patients with glioblastoma multiforme, a deadly form of brain cancer.
Similar news · Read more »
- Researchers identify genes that allow brain cancer-causing stem cells to resist treatment
12-14-2006 · EurekAlert!
Researchers at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute, who first isolated cancer stem cells in adult brain tumors in 2004, have now found these cells to be highly resistant to chemotherapy and other treatments. Even if a tumor is almost completely obliterated, it will regenerate from the surviving cancer stem cells and be even more resistant to treatment than before.
Similar news · Read more »
- Genetically modified cells attack tumors
12-21-2006 · EurekAlert!
Mice with neuroblastoma tumors have been successfully treated with genetically modified cells that sought out the cancer cells and activated a chemotherapy drug directly at those sites, according to investigators at St. Jude Children's Research Hospital and their colleagues at City of Hope National Medical Center (Duarte, Calif.) and the University of British Columbia (Vancouver, Canada). Neuroblastoma is a solid tumor that arises in the part of the nervous system outside the brain.
Similar news · Read more »
- On the road to a new cancer therapy -- starving the tumor
11-01-2007 · EurekAlert!
VIB scientists connected to the Katholieke Universiteit Leuven, in collaboration with the Flemish biotech company ThromboGenics, have been studying the anticancer action of anti-PLGF. This substance appears not only successful in treatment of tumors for which the current therapies fail, but also contributes to the greater effectiveness of existing chemotherapy, without side effects. Thus, anti-PLGF might possibly form the basis for new treatment for cancer.
Similar news · Read more »
- Allergy drug slows pancreatic tumor growth in preclinical studies
12-19-2006 · EurekAlert!
An anti-allergy drug in use for more than 40 years significantly reduced tumor growth in animal models of human pancreatic cancer and also increased the effectiveness of standard chemotherapy, say researchers at the University of Texas M. D. Anderson Cancer Center.
Similar news · Read more »
- Temple University Hospital investigates new prophylactic HPV vaccine
01-30-2007 · EurekAlert!
Temple University Hospital's Center For Women's Health is participating in a national study to determine the safety and effectiveness of an investigational treatment for cervical dysplasia. According to the American Cancer Society, approximately 500,000 women are diagnosed with high-grade cervical dysplasia each year, with roughly 10,000 cases progressing to cervical cancer.The expected widespread availability of two preventive vaccines may lower the incidence of HPV infection and reduce the risk of cervical cancer.
Similar news · Read more »
